Russell Investments Group Ltd. Sells 14,700 Shares of Transcat, Inc. (NASDAQ:TRNS)

Russell Investments Group Ltd. lowered its position in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 72.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 5,571 shares of the scientific and technical instruments company's stock after selling 14,700 shares during the quarter. Russell Investments Group Ltd. owned about 0.06% of Transcat worth $589,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in TRNS. Geode Capital Management LLC boosted its holdings in Transcat by 5.4% during the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company's stock valued at $26,269,000 after acquiring an additional 11,106 shares during the period. Annex Advisory Services LLC raised its position in Transcat by 47.6% in the 4th quarter. Annex Advisory Services LLC now owns 24,461 shares of the scientific and technical instruments company's stock worth $2,587,000 after buying an additional 7,893 shares during the last quarter. Rhumbline Advisers boosted its holdings in shares of Transcat by 4.1% during the 4th quarter. Rhumbline Advisers now owns 12,348 shares of the scientific and technical instruments company's stock valued at $1,306,000 after acquiring an additional 486 shares during the last quarter. Barclays PLC grew its holdings in shares of Transcat by 393.0% in the third quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company's stock worth $1,826,000 after acquiring an additional 12,061 shares during the period. Finally, Principal Financial Group Inc. boosted its holdings in shares of Transcat by 8.5% in the fourth quarter. Principal Financial Group Inc. now owns 5,002 shares of the scientific and technical instruments company's stock worth $529,000 after buying an additional 391 shares during the last quarter. Hedge funds and other institutional investors own 98.34% of the company's stock.

Transcat Trading Up 0.8 %

Shares of TRNS stock opened at $84.23 on Wednesday. The stock's 50-day moving average price is $77.11 and its 200-day moving average price is $95.15. Transcat, Inc. has a 12-month low of $67.56 and a 12-month high of $147.12. The company has a current ratio of 2.42, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $784.10 million, a price-to-earnings ratio of 45.53 and a beta of 0.67.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same period last year, the company earned $0.56 earnings per share. Equities research analysts predict that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. StockNews.com cut shares of Transcat from a "hold" rating to a "sell" rating in a research note on Wednesday, February 5th. Oppenheimer downgraded shares of Transcat from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. Northland Securities reaffirmed a "market perform" rating and issued a $85.00 target price (down previously from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Finally, HC Wainwright dropped their price target on Transcat from $126.00 to $106.00 and set a "buy" rating for the company in a research note on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Transcat currently has a consensus rating of "Hold" and an average price target of $111.50.

Insider Transactions at Transcat

In related news, Director Craig D. Cairns purchased 1,200 shares of Transcat stock in a transaction that occurred on Friday, January 31st. The shares were bought at an average price of $77.02 per share, with a total value of $92,424.00. Following the purchase, the director now directly owns 1,910 shares of the company's stock, valued at approximately $147,108.20. This represents a 169.01 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 2.30% of the company's stock.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.